TASK heads into the post-earnings tape with the most significant short-covering story it has seen in months.
The clearest signal is the dramatic unwind in short positioning. Short interest peaked at nearly 17.6% of free float around April 10 — a level consistent with heavy bearish conviction ahead of Q1 results. It has since collapsed to 11.3%, a drop of more than a third in under four weeks. The timing is telling: bears appear to have been scaling back since mid-April, and the catalyst arrived on May 6 when TaskUs reported Q1 adjusted EPS of $0.35 — a $0.01 beat — with revenue of $306.3 million, exceeding consensus by roughly $9.6 million. Q2 sales guidance of $296–298 million landed in line with estimates, and the company affirmed its full-year revenue range of $1.21–1.24 billion. That was enough to wrong-foot a short base that had been building since March.
The lending market tells a story of relief rather than stress. Borrow availability is wide — the borrow rate has eased to under 1% (0.91% APR), well below the 1.35% seen in early April. The utilization rate has dropped sharply, from nearly 49% at its April 10 peak to just 15%, confirming that the rush to borrow shares for short positions is over. Options positioning reinforces the relaxed tone: the put/call ratio of 0.25 is below its 20-day average of 0.28, with a z-score of just -0.42 — there is no elevated demand for downside protection. The 52-week PCR range is wide (0.0 to 2.43), so the current reading barely registers as defensive.
The Street remains cautious on the recovery story, even if shorts are less so. The mean analyst price target of $12.00 implies roughly 88% upside from the $6.39 close — a gap that reflects either deep scepticism about execution or stale assumptions. Morgan Stanley lowered its target from $16.50 to $12.00 in early March while holding Equal-Weight. Wedbush maintained its Outperform and a $14 target as recently as April 15, but even that view implies the stock needs to more than double to reach conviction. The valuation is unambiguously cheap: EV/EBITDA of 2.8x and a P/E of 4.5x leave room for a re-rating if revenue trends stabilise, though EPS forward momentum is weak — the 90-day EPS momentum percentile sits at just 14. The dividend score ranks in the 86th percentile, driven by the $3.65 special cash dividend declared in February, which implies a trailing yield north of 12%. That payout is a one-time event, not a recurring commitment, so the yield figure should be read carefully.
Ownership is concentrated and management has been selling. Blackstone holds 51.5% of shares and has not changed its position in recent reported periods. The co-founders — CEO Bryce Maddock and Jaspar Weir — together hold another 27.5% and both received equity awards in late March. Yet the broader insider picture leans negative: the CFO, General Counsel, and Chief Customer Officer all sold stock in late March and early April at prices between $6.54 and $6.89. Net insider activity over 90 days is a modest positive at around $1 million due to award accounting, but the cash-sale direction among senior leaders is worth noting at a stock already 46% lower year-to-date. A notable institutional entry: Saba Capital initiated a 2% stake, and Aberdeen Group added a 1.5% position as recently as March — both fresh buys into the dip.
RSI of 35 confirms the stock remains technically oversold, and the short-score at 52 sits squarely in neutral territory after pulling back from mid-April highs near 54. The next test is the Q1 earnings call scheduled for May 8 — the question for the remaining short base, now less than half its April peak, is whether the revenue beat and affirmed guidance are enough to drive a sustained re-rating, or whether execution concerns around AI-service scaling and customer concentration keep the recovery shallow.
See the live data behind this article on ORTEX.
Open TASK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
